Tu Karen, Campbell Norman R C, Chen Zhongliang, McAlister Finlay A
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Am J Geriatr Pharmacother. 2006 Jun;4(2):161-7. doi: 10.1016/j.amjopharm.2006.06.004.
Although several small studies have reported underuse of thiazide diuretics for elderly hypertensive patients, those factors which influence initial choice of first-line antihypertensive treatment are unknown.
: The objective of this study was to explore prescribing practices for antihypertensives in the elderly and determine which factors are associated with thiazide diuretic use as first-line treatment
This population-based cohort study used linked administrative databases for all elderly patients (> or =66 years of age) first treated for hypertension between July 1, 1994, and March 31, 2002, in Ontario, Canada.
Of the 194,761 patients in our cohort, 68,858 (35%) were prescribed a thiazide diuretic as their first anti-hypertensive agent. On multivariate analysis, factors associated with being prescribed a thiazide as first-line treatment included age (adjusted odds ratio [AOR], 1.72 [95% CI, 1.67-1.78] for octogenarians compared with patients aged 66-69 years) and having multiple comorbidities (AOR, 1.24 [95% CI, 1.16-1.29] for Charlson scores of 2 and AOR, 1.52 [95% CI, 1.37-1.61] for Charlson scores of > or =3). On the other hand, men (AOR, 0.64 [95% CI 0.63-0.65]) and hypertensives with diabetes (AOR, 0.22 [95% CI, 0.21-0.23]) were substantially less likely to be prescribed thiazide diuretics as first-line treatment. Socioeconomic status was not associated with use of thiazide diuretics.
One third of initial antihypertensive prescriptions for elderly patients were for thiazides in our publicly funded health care system with universal drug coverage. Socioeconomic status did not influence use of thiazides, but age, sex, and comorbidities did.
尽管有几项小型研究报告称老年高血压患者噻嗪类利尿剂使用不足,但影响一线降压治疗初始选择的因素尚不清楚。
本研究的目的是探讨老年人抗高血压药物的处方习惯,并确定哪些因素与噻嗪类利尿剂作为一线治疗的使用有关。
这项基于人群的队列研究使用了加拿大安大略省1994年7月1日至2002年3月31日期间首次接受高血压治疗的所有老年患者(≥66岁)的关联行政数据库。
在我们队列中的194,761名患者中,68,858名(35%)被开了噻嗪类利尿剂作为他们的第一种抗高血压药物。多变量分析显示,与被开噻嗪类作为一线治疗相关的因素包括年龄(与66 - 69岁患者相比,八旬老人的调整优势比[AOR]为1.72 [95%可信区间,1.67 - 1.78])和患有多种合并症(Charlson评分为2时的AOR为1.24 [95%可信区间,1.16 - 1.29],Charlson评分为≥3时的AOR为1.52 [95%可信区间,1.37 - 1.61])。另一方面,男性(AOR为0.64 [95%可信区间0.63 - 0.65])和患有糖尿病的高血压患者(AOR为0.22 [95%可信区间,0.21 - 0.23])作为一线治疗被开噻嗪类利尿剂的可能性要小得多。社会经济地位与噻嗪类利尿剂的使用无关。
在我们有全民药物覆盖的公共资助医疗保健系统中,老年患者初始抗高血压处方中有三分之一是噻嗪类药物。社会经济地位不影响噻嗪类药物的使用,但年龄、性别和合并症会影响。